Lion X Ventures
VC Fund
Singapore, Singapore
Lion X Ventures is an investment firm.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Lion X Ventures invests in
Stages Lion X Ventures invests in
Countries Lion X Ventures invests in
Investment Focus
Industry
- Artificial Intelligence 3 (50%)
- FinTech 2 (33%)
- Banking 1 (17%)
- Software 1 (17%)
- Insurance 1 (17%)
Stage
- Series C 2 (33%)
- Series A 1 (17%)
- Series B 1 (17%)
- Funding Round 1 (17%)
Country
- China 1 (17%)
- Indonesia 1 (17%)
- Singapore 1 (17%)
- South Korea 1 (17%)
- United States 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
AIsphere
|
AIsphere focuses on visual multimodal large models and empowering content producers in many sectors and scenarios with AIGC technology. | $139M / Series C / Jul 14, 2026 | |
|
AIsphere
|
AIsphere focuses on visual multimodal large models and empowering content producers in many sectors and scenarios with AIGC technology. | $300M / Series C / Mar 12, 2026 | |
Dyna.Ai
|
Dyna.Ai is a leading AI-as-a-Service company headquartered in Singapore, dedicated to transforming the finance industry and beyond with cutting-edge AI-driven products and solutions. Our expertise encompasses state-of-the-art AI models, sophisticated algorithms, AI-human interaction technologies, and big data analytics. These capabilities enableus to deliver top-tier AI solutions that empower our clients to achieve business success and maintain a competitive edge in a rapidly evolving market. At Dyna.Ai, we are committed to harnessing advanced AI technology to provide innovative, industry-specific solutions for the financial sector and others, improving marketing, risk management, customer experience and employee experience, while driving productivity and efficiency across enterprises.Mission: Empower Work, Enrich Life Slogan: AI Revolutionize Finance | Series A / Mar 02, 2026 | |
Setlary
|
Setlary provides Essential Wage Access (EWA) services, allowing individuals to receive earned salaries early for financial flexibility while assisting businesses in optimising cash flow through rebates. | Dec 02, 2025 | |
Rebellions
|
AI chip architects are often inattentive to advanced deep learning features and requirements because they believe software stacks between their silicon and algorithms can provide effective abstract layers. We disagree. We do not think such naively designed chips can efficiently utilize expensive custom silicon resources. The more native hardwaresupports are enabled, the higher performance is achieved.Rebellions Inc is building genuine AI accelerators by bi-directionally bridging the gap between underlying silicon architectures and deep learning algorithms. We push algorithm boundaries to better exploit silicon budgets, while re-architecting AI processors to incorporate sophisticated deep learning features through silicon-dedicated DL kernels.Our goal is to deliver a domain-specific AI processor along with its optimized software. This approach, together with our unique decentralized programming model, will enable customers to arm with the most powerful yet energy-efficient AI hardware as well as seamless integration. | $250M / Series C / Sep 30, 2025 | |
AWAK Technologies
|
AWAK Technologies develop wearable dialysis machines, 1kg and battery-operated, for continuous dialysis. The company was certified by SGS for ISO 13485 Quality Management System in September 2008 with the scope of designing, manufacturing and distributing medical devices.The Automated Wearable Artificial Kidney (AWAK) is based on tidalperitoneal dialysis. The technology is based on research by Profs David Lee & Martin Roberts of UCLA and VA Systems.The engineering and development of AWAK is done in Singapore with the collaboration of Temasek Polytechnic.The company has completed the R&D and is now in the clinical trial stage, targeting both FDA and CE certifications. The AWAK Regular Cartridge, is currently in pilot production stage and expected to enter clinical trial by the end of 2012. This wearable artificial kidney operates continuouslyand functions like a normal kidney. Being small , light (less than 1 kg) and battery-operated, the patients will be able to go about having daily routines, with no restriction to lifestyles such as work, travel and leisure. | $20M / Series B / Sep 13, 2023 |
Co-Investors
iGlobe Partners
2 deals together
Advanced MedTech
1 deal together
ADATA Technology
1 deal together
Alibaba Group
1 deal together
Arm Holdings
1 deal together
Blue Focus PR Consulting
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Lion X Ventures invest in?
Lion X Ventures invests primarily in Artificial Intelligence, FinTech and Banking startups, most often at Series C and Series A stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Lion X Ventures last invest?
The most recent investment recorded for Lion X Ventures closed in Jul 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
